Acutaas Chemicals Limited has scheduled an earnings conference call to discuss its unaudited financial results for the first quarter ended June 30, 2026. The meeting is set to take place on Friday, July 24, 2026, at 4:00 PM IST, providing investors an opportunity to review the company's performance for Q1FY27.

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Nuvama Wealth Management is hosting the post-result conference call, which will feature key members of the company's management team.

Management Participation

Senior executives representing Acutaas Chemicals on the call will include:

• Mr. Naresh Patel – Chairman and Managing Director
• Mr. Bhavin Shah – Chief Financial Officer
• Mr. Abhishek Patel – President (Strategy)

Mr. Archit Joshi of Nuvama Wealth Management Ltd. will serve as the call leader.

Conference Call Details

Participants can join the discussion via the following dial-in numbers:

For further information, stakeholders may contact Archit Joshi via email at Archit.Joshi@nuvama.com .

Acutaas Chemicals has promoted Anurag Shukla to the role of General Manager Operations & Unit Head – Ankleshwar, effective July 2, 2026. The company's Nomination and Remuneration Committee approved the designation of Shukla as a Senior Management Personnel (SMP) during a meeting held on the same date. This strategic elevation aims to strengthen the leadership overseeing the company's manufacturing facility in Ankleshwar.

Shukla has been associated with the company since September 1, 2021, joining as a Senior Manager before serving as Assistant General Manager – Operations. In his new capacity, he will be responsible for overseeing the overall operations of the Ankleshwar manufacturing facility. He brings over 21 years of experience in pharmaceutical API and intermediates manufacturing, plant operations, and regulatory compliances.

The appointment was intimated to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was also read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Profile of the Appointee

Shukla holds a Master of Science in Organic Chemistry. His expertise includes setting up manufacturing facilities, leading regulatory audits by global agencies, driving operational excellence, and cost optimisation. Prior to joining Acutaas Chemicals, he held leadership positions at Alembic Pharmaceuticals Limited, IPCA Laboratories Limited, Dishman Pharmaceuticals & Chemicals Limited, Kalki Healthcare Private Limited, and Avitech Nutrition Private Limited.

Key Appointment Details